FOGNANI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 3.069
EU - Europa 2.106
AS - Asia 892
SA - Sud America 154
AF - Africa 21
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.262
Nazione #
US - Stati Uniti d'America 3.038
PL - Polonia 727
RU - Federazione Russa 689
SG - Singapore 253
CN - Cina 190
HK - Hong Kong 186
IE - Irlanda 166
IT - Italia 166
SE - Svezia 131
BR - Brasile 124
KR - Corea 79
VN - Vietnam 76
DE - Germania 70
FI - Finlandia 46
IN - India 33
GB - Regno Unito 32
ES - Italia 21
ID - Indonesia 20
AU - Australia 19
CA - Canada 16
AR - Argentina 15
JO - Giordania 15
TR - Turchia 14
BE - Belgio 13
FR - Francia 13
MX - Messico 11
NL - Olanda 9
CI - Costa d'Avorio 7
IQ - Iraq 6
ZA - Sudafrica 6
EC - Ecuador 5
JP - Giappone 5
UA - Ucraina 5
BD - Bangladesh 4
CO - Colombia 4
MA - Marocco 4
RO - Romania 4
HU - Ungheria 3
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
HN - Honduras 2
MD - Moldavia 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 6.262
Città #
Santa Clara 803
Warsaw 724
Ashburn 296
Fairfield 279
Dublin 166
Hong Kong 153
Woodbridge 144
Chandler 143
Singapore 143
Cambridge 123
Seattle 121
Houston 114
Wilmington 109
Beijing 107
Ann Arbor 81
Seoul 76
Altamura 56
Florence 54
Lawrence 49
The Dalles 48
Buffalo 46
Princeton 46
Bremen 33
Mumbai 27
Los Angeles 25
Munich 25
Boston 24
Medford 23
New York 21
Dong Ket 20
Falls Church 20
Ho Chi Minh City 20
Shanghai 20
Boardman 19
Melbourne 19
Jakarta 14
San Diego 14
Brussels 13
Dallas 13
Hanoi 12
Barcelona 11
Clifton 11
Norwalk 10
São Paulo 10
Izmir 9
London 9
Moscow 9
Turku 9
Abidjan 7
Cagliari 7
Jacksonville 7
Old Bridge 7
Phoenix 7
Montreal 6
Redondo Beach 6
Atlanta 5
Frankfurt am Main 5
Lauterbourg 5
Avigliano 4
Brooklyn 4
Chicago 4
Cluj-Napoca 4
Curitiba 4
Istanbul 4
Johannesburg 4
Madrid 4
Mexico City 4
Washington 4
Andover 3
Brasília 3
Da Nang 3
Ferriere 3
Manaus 3
Paris 3
Pistoia 3
Salt Lake City 3
Tokyo 3
Toronto 3
Aachen 2
Asunción 2
Baghdad 2
Bastia umbra 2
Bern 2
Biên Hòa 2
Budapest 2
Campina Grande 2
Can Tho 2
Chennai 2
Chisinau 2
Contagem 2
Forlì 2
Fortaleza 2
Guayaquil 2
Hefei 2
Helsinki 2
Hillsboro 2
Itajubá 2
João Pessoa 2
Kofu 2
Laurel 2
Totale 4.497
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 311
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 301
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. 243
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 235
Determinanti virali e dell’ospite nella patogenesi dei disordini linfoproliferativi HCV-correlati 219
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 213
A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens 210
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 208
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 202
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 198
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 195
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 193
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 191
Host genetic determinants in HCV-related mixed cryoglobulinemia 181
IgG3 subclass: A possible trigger of mixed cryoglobulin cascade in hepatitis C virus chronic infection 177
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 175
Host genetic determinants in HCV-related mixed cryoglobulinemia 173
MicroRNA expression in hepatitis C virus-related malignancies: A brief review 170
Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame? 153
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 149
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 149
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 148
Host genetic determinants in HCV-related mixed cryoglobulinemia 145
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 133
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 132
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 130
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 124
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 124
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 122
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. 120
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 116
HCV AND lymphoma: Genetic and epigenetic factors 116
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life 110
Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26 106
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 105
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 103
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 103
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 98
Totale 6.281
Categoria #
all - tutte 16.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 45 29 44 46 88 26 28
2021/2022316 4 26 21 16 17 23 7 22 17 17 50 96
2022/2023768 69 120 43 65 60 137 98 47 86 2 26 15
2023/2024214 10 36 41 9 9 30 3 54 4 4 5 9
2024/20251.991 85 187 124 279 641 311 14 112 91 38 63 46
2025/20261.002 238 233 96 171 197 67 0 0 0 0 0 0
Totale 6.281